Powered by collagen, Mānuka honey, and hydroxyapatite

VERIS™ is the first advanced wound care product to deliver on performance, ease, and affordability for the millions recovering from chronic and surgical wounds.

Now available exclusively with HARTMANN USA

Recovery starts with VERIS™

  • 2x Faster Wound Closure (1-3*)

  • Lower Reported Pain in Mohs Wounds (4*)

  • Simple, Non-Sticky

  • Reimbursable

Simple, Mess-Free Application

  • Provided in a convenient non-sticky sheet, VERIS™ is as simple as adding a layer under a bandage. Simply peel open, prep with saline, hydrate, place and cover.

  • For easy maintenance, VERIS™ dissolves daily as the wound progresses with no painful removal process.

Accessible

  • Order as a DME Supply. VERIS™ is reimbursed as a collagen, HCPCS A6021, by Medicare and many commercial plans.

  • Stock in the clinic. VERIS™ is widely available to order through our partners across multiple sites of service.

PATENTED MX® TECHNOLOGY

Unique Chemical Fingerprint, Broken Down to be Rebuilt.

  • MX™ combines three naturally derived ingredients to create a unique biomaterial, providing a foundation for innovative wound care solutions designed to support the body’s natural healing process. MX™ powers VERIS™.

    • A natural protein matrix known to benefit granulation + epithelialization

    • Known to attract and buffer elevated levels of MMPs

    • Known to inhibit bacterial growth and suppress MMP activity

    • Supports wound closure progress by increasing fibroblast activity

    • Provides structural reinforcement

    • Known to bind cell adhesion proteins

VERIS™ is Easy to Use

  • Doctor Illustration

    Clean

    before applying VERIS™

  • VERIS™ delivery box

    Prep

    with drops of sterile saline (do not soak)

  • VERIS™ wound care product

    Place

    gently and maximize contact with wound

  • Protect

    with bandage or cover dressing

The procedure may be repeated daily or according to physician instructions.

If VERIS™ has not fully dissolved at the time of a dressing change, the material may remain in place and be rehydrated with saline prior to application of a new dressing.

“

VERIS™ is not just hastening the closure of wounds; it empowers patients to take control of their recovery at home. Seamless for me and simple for my patients.

— GWEN BEARD, MD MOHS SURGEON / MEMPHIS DERMATOLOGY

VERIS™ in Action

  • Debridement + at-home VERIS™ application

  • 49-year-old non-diabetic female admitted to the hospital with cellulitis of the right lower extremity.

  • Pressure ulcer on the right dorsal foot, secondary to a blister. Present for more than one week with progressive worsening. Measured 1.5 × 1.5 × 0.6 cm at evaluation.

  • Debrided the wound at initial evaluation + prescribed VERIS™ for at-home self-application. SweetBio®'s logistics partner fulfilled the order + billed the patient's insurance, at no cost to the patient. Weekly in-office debridements followed.

  • Self-applied VERIS™ at home every two days between office visits.

  • Complete wound closure within four weeks.

  • "I was very pleased with the speed of healing, especially given the challenging location of this wound. I also appreciate the ability for the patient to self-apply VERIS™ at home, which allowed her to continue advanced wound care outside of the hospital or clinic setting."

    – Dr. Abhin Kumar, DPM, Podiatrist

Before + After

*Pictures taken and shared with patient consent.

View More Case Studies

Backed by Evidence

  • Clinical Publication: 37 Patient Mohs Dermatologic Surgery RCT

    Published in Dermatologic Surgery, this randomized controlled trial (RCT) conducted by the Dermatology Department at Vanderbilt University Medical Center compared SweetBio®’s technology and secondary intention healing (SIH) to support wound closure post-Mohs. Results demonstrated improved wound healing with SweetBio®’s technology showing significant reduction in pain scores and favorable skin thickness.

    Download

  • Clinical Publication: 12 Patient Lower Extremity Chronic Wound Case Series

    Published in The International Journal of Lower Extremity Wounds, this clinical evaluation involved 5 physicians across 4 states using SweetBio®’s technology to treat non-healing chronic ulcers. Patients achieved 100% closure within 8 weeks, with a mean closure time of 4.1 weeks.

    Download

  • Clinical Publication: 8 Patient Mohs Dermatologic Surgery Case Series

    Published in Dermatologic Surgery, this clinical evaluation conducted by the Dermatology Department at Vanderbilt University Medical Center used SweetBio®’s technology to support wound closure post Mohs (skin cancer removal) surgery. Results demonstrated complete re-epithelialization was achieved within an average of 6 weeks.

    Download

  • Clinical Publication: 43 Patient Chronic Wound Healing in an Urban Hospital Wound Clinic

    Published in Wounds, this retrospective IRB-approved clinical evaluation assessed chronic wound closure rates using standard of care (SOC) or treatment with SweetBio®’s technology in an urban hospital wound clinic. In both groups, most wounds did not close for several reasons, mainly patient compliance. For wounds that did close, the average time to closure was two times faster for SweetBio®’s technology compared to SOC (7.4 weeks and 14.8 weeks, respectively; p < .05).

    Download

  • In Vitro Publication: Bacteria Reduction

    Published in Biomedical & Translational Science, this data demonstrates SweetBio®’s technology ability to significantly reduce both Staphylococcus Aureus and Pseudomonas Aeruginosa by 99.99% compared to a non-treated surface after 24 hours, in vitro.

    Download

  • In Vitro Publication: Controlling Inflammation and Growth Factors

    Published in the International Journal of Biomaterials, this data demonstrates SweetBio®’s technology ability to significantly decrease (to negligible levels) the expression of MMP-9 from macrophages and trigger the release of pro-regenerative growth factors from fibroblasts such as FGFb and VEGF, in vitro.

    Download

  • In Vitro Publication: Direct Comparison of Collagen Dressing vs. Manuka Honey Dressing vs. SweetBio®’s Technology

    Published in the International Journal of Molecular Sciences, this data highlights the superior comprehensive approach that SweetBio®’s technology has over collagen dressings and Manuka honey dressings, specifically comparing MMP-9/TIMP-1 ratios and pro-regenerative growth factor secretion, in vitro.

    Download

“

The easy-to-use packaging of VERIS™ has made self-application convenient, even while traveling, allowing me to maintain my wound care routine without hassle.

— VERIS™ PATIENT

Frequently Asked Questions

VERIS™ OVERVIEW

  • Whether surgically created or stalled, VERIS™ can be used on most wounds. VERIS™ is FDA-cleared for the management of a variety of wounds, including surgical sites (Mohs, biopsies, etc.) and ulcers (diabetic, venous stasis, pressure).

    Indications:

    Full and Partial-Thickness Wounds

    Pressure Ulcers (Stages I -IV)

    Venous Stasis Ulcers

    Diabetic Ulcers

    Surface Wounds

    Traumatic Wounds

    Surgical Wounds

    Abrasions

    Donor Sites

  • Powered by a patented combination of 3 natural ingredients, VERIS™ is a one-of-a-kind solution backed by science. Ingredients:

    • Collagen Derivative: A natural extracellular matrix protein, an essential part of organic tissue. (8)

    • 100% UMF™-Certified New Zealand Mānuka Honey: Known for antibacterial properties and aiding in wound healing. (9)

    • Hydroxyapatite: A naturally occurring mineral known to add structural reinforcement to biomaterials and promote wound healing via angiogenesis and re-epithelialization. (10)

  • VERIS™ was created by SweetBio, Inc. Learn more about SweetBio's mission and values here.

  • VERIS™ is made with SweetBio®’s technology, MX™, which addresses the wound's microenvironment by balancing key variables known to heavily impact both early stages (i.e., homeostasis and inflammatory phases) and late stages (i.e., proliferation and remodeling phases) of the wound healing process. (5-7*)

  • VERIS™ is covered by Medicare as a wound care supply (A6021, Collagen). Depending on the policy, VERIS™ may be covered by commercial plans.

  • There is no FDA-cleared claim for VERIS™ or any other Mānuka honey product on the market as an antibacterial product. However, Mānuka honey is well-researched for its antibacterial properties, and SweetBio®’s MX™ technology has demonstrated a remarkable 99.99% reduction in gram-positive and gram-negative bacteria in vitro, which is published in peer-reviewed journals. (5*)

  • Yes, the Mānuka honey used in VERIS™ is 100% UMF certified and medical grade, which is filtered and sterilized.

TIPS FOR THE BEST VERIS™ EXPERIENCE

  • SweetBio® will provide an easy-to-follow script for you to support your patient’s expectations.

    Email info@sweetbio.com for patient educational materials.

  • Since VERIS™ is made with natural ingredients, you might notice variations in shape, size, or color from one side to the other. That’s completely normal—and either side can be placed on the wound.

  • Several drops of saline are sufficient to moisten VERIS™. This helps it soften, conform to the wound, and support a moist healing environment. VERIS™ should be wet, not soaking or dripping, to avoid saturating the covering bandage. Note that VERIS™ may expand slightly as it hydrates with saline.

  • You might notice a scent when opening the pouch. It’s from the natural material composition and protein-binding process and will fade quickly.

  • VERIS™ must contact as much of the wound as possible and does not need to overlap the edges of the wound. Gently press to ensure it contacts the wound.

  • On average, VERIS™ dissolves daily. Apply a new VERIS™ product per your recommendation.

  • If VERIS™ hasn’t fully dissolved when changing the bandage (either at home or at the clinic), do not remove it— simply add a few drops of saline and cover with a new bandage.

  • Contraindications

    • Patients with sensitivity to collagen and its derivatives

    • Patients with sensitivity to porcine-derived products

    • Patients with sensitivity to honey

    • Third degree burns

    • Infections or contamination in the wound site

    • Control of bleeding

    • Children and infant patients under 10kg / 22lbs

    Usage Information

    • Users should follow the most recent procedures and best practices for wound management to complete wound preparation, application of VERIS™ and application of secondary dressings.

    • Remove VERIS™ and discontinue use if signs of sensitivity appear.

    • Do not use VERIS™ after the expiration date stated on the product label.

    Contact a health care professional if:

    • Signs of infection occur (e.g. increased pain)

    • There is a change in wound color and/or odor

    • The wound does not begin to show signs of healing, or

    • Any other unexpected symptom

We're here to support your patients!

  • Got questions?

    The safety and well-being of our patients and those that care for them is what matters most. You can count on us through every step.

    Contact

  • Request Sample

    Experience the VERIS™ difference.

    Request

  • Clinical In-Service

    Request a clinical in-service visit with Dr. Isaac Rodriguez, the co-inventor of VERIS™ and Chief Science Officer at SweetBio®.

    Schedule

  • Submit a Case Study

    Share your patients' success stories with us.

    Share